PROCEPT BioRobotics Corporation (PRCT) Earnings History
Annual and quarterly earnings data from 2019 to 2025
Loading earnings history...
PRCT EPS Growth (CAGR)
Compound annual growth rate of diluted earnings per share
CAGR (Compound Annual Growth Rate) shows the annualized growth rate of EPS over the specified period. A higher CAGR indicates stronger earnings momentum.
PRCT Profitability Analysis
Margin trends over time
| Year | Gross Margin | Operating Margin | Net Margin |
|---|---|---|---|
| 2025 | 63.7% | -33.7% | -31.0% |
| 2024 | 61.1% | -43.0% | -40.7% |
| 2023 | 52.2% | -80.2% | -77.8% |
| 2022 | 49.4% | -107.6% | -116.2% |
| 2021 | 46.0% | -157.1% | -173.6% |
Download Data
Export PRCT earnings history in CSV or JSON format
Free sign-in required to download data
PROCEPT BioRobotics Corporation (PRCT) Earnings Overview
As of May 7, 2026, PROCEPT BioRobotics Corporation (PRCT) reported trailing twelve-month net income of -$102M, reflecting +1.7% year-over-year growth. The company earned $-1.81 per diluted share over the past four quarters, with a net profit margin of -31.0%.
Looking at the long-term picture, PRCT's historical earnings data spans multiple years. The company achieved its highest annual net income of -$42M in fiscal 2019.
PROCEPT BioRobotics Corporation is currently reporting a net loss, though operating performance should be evaluated in the context of growth investments and industry dynamics View revenue history →
Compared to peers including ISRG ($2.98B net income, 28.4% margin), NVCR (-$173M net income, -20.8% margin), NTRA (-$309M net income, -11.2% margin), PRCT has room to improve margins relative to the peer group. Compare PRCT vs ISRG →
PRCT Earnings vs Peers
Earnings metrics vs comparable public companies
PRCT Historical Earnings Data (2019–2025)
7 years| Fiscal Year | Net Income | YoY % | Operating Income | EPS (Diluted) | Net Margin | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | -$96M | -4.5% | -$104M | $-1.72 | -31.0% | -33.7% |
| 2024 | -$91M | +13.7% | -$97M | $-1.75 | -40.7% | -43.0% |
| 2023 | -$106M | -21.5% | -$109M | $-2.24 | -77.8% | -80.2% |
| 2022 | -$87M | -45.6% | -$81M | $-1.96 | -116.2% | -107.6% |
| 2021 | -$60M | -12.9% | -$54M | $-1.37 | -173.6% | -157.1% |
| 2020 | -$53M | -26.3% | -$48M | $-1.51 | -687.0% | -619.4% |
| 2019 | -$42M | - | -$44M | $-1.25 | -680.4% | -705.9% |
See PRCT's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs PRCT Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare PRCT vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonPRCT — Frequently Asked Questions
Quick answers to the most common questions about buying PRCT stock.
Is PRCT growing earnings?
PRCT EPS of $-1.81 reflects slowing growth at +1.7%, below the 5-year CAGR of N/A. TTM net income is $-102M. Expansion rate has moderated.
What are PRCT's profit margins?
PROCEPT BioRobotics Corporation net margin is -31.0%, with operating margin at -33.7%. Below-average margins reflect competitive or cost pressures.
How consistent are PRCT's earnings?
PRCT earnings data spans 2019-2025. The current earnings trend is +1.7% YoY. Historical data enables comparison across business cycles.